Ali Byrd brings 15 years of operating and advisory experience within the technology industry spanning sales, marketing, consulting, finance and R&D. In the Investment Banking Division of Lehman Brothers, he coordinated deal team execution and conducted in-depth industry assessments, focused on software, services and communications technology clients. Previously, Mr. Byrd spent over 9 years at Microsoft, where he led due-diligence and post-merger management and launched 3 global product introductions for $12 billion Information Worker business unit. Mr. Byrd is currently Vice President of Strategy and Corporate Development at Lime Wire, a leading Internet software company headquartered in New York City.

Mr. Byrd holds an MBA from the Wharton School at the University of Pennsylvania and a BS in Electrical Engineering from Duke University.  

Armen Orujyan, PhD is Founder and Chairman of the Board of Athgo Corporation, a US nonprofit organization since 1999. For over a decade, Armen has been developing and providing entrepreneurial platforms for young people with leading global institutions. These efforts have included coordination with the United Nations Department of Economic and Social Affairs; UN NGO Section; UN University; UN Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries, and Small Island Developing States; UN Global Alliance for Information and Communication Technologies and Development (UN GAID); World Intellectual Property Organization; the World Bank’s External Affairs Department; and a number of Governments both in developed and emerging countries.

Focusing on his expertise in nonprofit management, Armen has built on those strong international and governmental networks to establish support among the Fortune 100 firms such as Boeing, Dell, Intel Corporation, and Northrop Grumman; and cultivate partnerships with leading academic institutions and broader public sectors to advance entrepreneurial opportunity for Athgo’s youth stakeholders. Under his leadership, since 2003 Athgo has developed and is managing a strong network of over 100,000 young people worldwide. The United Nations acknowledges Armen’s dedication and Athgo’s unique position in offering young people opportunities to develop innovative business approaches that advance UN Millennium Development Goals; accordingly, in April 2008 the body appointed him the UN e-Leader (Ambassador) for Youth and ICTs. Armen has served as a consultant for various US political campaigns, including Presidential. He remains involved in many national and international contests, and currently serves as a member of the Steering Committee of the UN GAID. Armen is also a certified presenter of Nobel Peace Prize Laureate, former US Vice President Al Gore's Climate Project. Armen is invited and frequently speaks at international conferences about the importance and necessity of young people’s engagement in global affairs, including entrepreneurship, environmental sustainability and information and communication technology (ICT) advancement and development.

Armen earned his Bachelor of Arts degree with Honors in Political Science from UCLA and received his Master of Arts degree in International Studies as well as PhD in Political Science from Claremont Graduate University in California.

 Dr. Chad Womack, Founder, President and Chair of TBED21, a non-profit organization dedicated to empowering urban centers and underserved communities through science, technology and innovation. As the President and Chair, Dr. Womack works closely with the Board to provide leadership and strategic vision for the organization, while working with executive staff to execute the organizations programmatic efforts. Dr. Womack is also the Founder and Executive Director of the Philadelphia Biotechnology and Life Sciences Institute - a non-profit initiative and project of TBED21, founded to address human capital/workforce development and bio-entrepreneurship issues for the bio-life sciences industry in the Greater Philadelphia Area. Dr. Womack has recently served as Vice President for Educational and Training Initiatives at the University City Science Center in Philadelphia. Dr. Womack is also the co-founder of NanoVec, Inc. a nanobiotechnology company and has served as its Chief Scientific Officer since its inception. He is also a co-founder, President and Chair of the National Association for Blacks in BIO (NABB), a non-profit organization dedicated to building diverse community within the biotechnology and life science industry.

Before coming to the Science Center and the founding of TBED21 and the Philadelphia Biotechnology and Life Sciences Institute, Dr. Womack recently held the position of tenure-track Assistant Professor at the Howard University College of Medicine in Washington, D.C. Prior to his appointment at Howard University, Dr. Womack completed several research fellowships at the National Institutes of Health (NIH), most recently at the National Institutes for Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC). As a NIAID research fellow and later as a senior fellow at the VRC, Dr. Womack conducted research on the immunopathogenesis of HIV/AIDS and AIDS vaccine development in developing countries, collaborating with investigators in India and Africa. Dr. Womack earned his Ph.D. from Morehouse School of Medicine while completing graduate thesis research at Harvard AIDS Institute and the Harvard School of Public Health in Boston. In addition to his thesis work, Dr. Womack was the principal investigator on a Fogarty Center funded project that resulted in the first analysis of HIV/AIDS health care utilization for HIV/AIDS patients in the city of Mumbai (Bombay), India. Upon earning his Ph.D., Dr. Womack completed a year of post-doctoral research at the Harvard AIDS Institute, where he continued his international HIV/AIDS research and collaborations in India.

Dr. Womack is a graduate of Morehouse College earning his B.S. degree with honors in Biology and minors in Chemistry and Applied Physics, and his Ph.D. in Biomedical Sciences from the Morehouse School of Medicine.